Understanding the ICD-10 code for MSSA is essential for accurate medical billing, precise clinical documentation, and effective patient care management. Methicillin-Sensitive Staphylococcus Aureus (MSSA) represents a specific bacterial strain requiring distinct identification within healthcare settings, and proper coding ensures that treatment protocols align with regulatory and reimbursement standards.
What is MSSA and Why Specific Coding Matters
MSSA refers to a strain of Staphylococcus aureus bacteria that remains susceptible to methicillin and other related antibiotics, distinguishing it from the more concerning Methicillin-Resistant Staphylococcus Aureus (MRSA). Accurate ICD-10 coding for MSSA infections is critical because it directly influences treatment pathways, hospital resource allocation, and epidemiological tracking. Misclassification can lead to inappropriate therapy delays or incorrect billing, impacting both clinical outcomes and financial operations within healthcare facilities.
Primary ICD-10 Codes for MSSA Infections
The specific ICD-10 code used depends heavily on the infection site and clinical context. There is no single "MSSA" code; instead, providers select codes that detail the condition and specify the organism. The following table outlines the primary codes utilized:
ICD-10 Code | Description | Common Usage
A49.12 | Methicillin-susceptible Staphylococcus aureus [MSSA] infection | Primary code for confirmed MSSA infections when site is not specified or is non-billable
A49.02 | Methicillin-susceptible Staphylococcus aureus [MSSA] sepsis | Specific code for sepsis caused by MSSA
L02.211 | Furuncle and carbuncle of face | Used when a furuncle is clinically documented as MSSA
J15.212 | Methicillin-susceptible Staphylococcus aureus pneumonia | Specific pneumonia caused by MSSA
How to Apply the Codes in Clinical Documentation Clinical documentation must clearly state the infection site and confirm MSSA status through culture results. Coders then assign the specific site code (such as J15.212 for pneumonia) and may include A49.12 as an additional code to explicitly identify the MSSA organism. When a site-specific code with the organism is available, it is generally prioritized to provide the highest level of specificity. For example, a knee infection caused by MSSA would be coded using L02.311 (Furuncle of knee) combined with A49.12 to fully capture the clinical picture. Distinguishing MSSA from MRSA in Billing and Statistics
Clinical documentation must clearly state the infection site and confirm MSSA status through culture results. Coders then assign the specific site code (such as J15.212 for pneumonia) and may include A49.12 as an additional code to explicitly identify the MSSA organism. When a site-specific code with the organism is available, it is generally prioritized to provide the highest level of specificity. For example, a knee infection caused by MSSA would be coded using L02.311 (Furuncle of knee) combined with A49.12 to fully capture the clinical picture.
The distinction between MSSA and MRSA is more than microbiological; it has significant implications for public health data and hospital-acquired infection rates. MRSA often triggers isolation protocols and may influence reimbursement in certain pay-for-performance models. Therefore, precise identification ensures that hospitals are appropriately credited for the complexity of care required. Accurate coding supports antimicrobial stewardship programs by tracking trends in susceptibility patterns and guiding empirical therapy decisions at the population level.
